{
    "organizations": [],
    "uuid": "61eee7ecf7bdbc3bf4909eeb8e4276f89a00c6c2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cas-group-delivers-letter-to-the-s/brief-cas-group-delivers-letter-to-the-stockholders-of-aviragen-idUSFWN1PJ11R",
    "ord_in_thread": 0,
    "title": "BRIEF-CAS Group Delivers Letter To The Stockholders Of Aviragen",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 24, 2018 / 2:18 PM / in 4 minutes BRIEF-CAS Group Delivers Letter To The Stockholders Of Aviragen Reuters Staff \nJan 24 (Reuters) - Aviragen Therapeutics Inc: \n* CAS GROUP DELIVERS LETTER TO THE STOCKHOLDERS OF AVIRAGEN \n* CAS GROUP SAYS PROPOSED MERGER BETWEEN AVIRAGEN AND VAXART NOT IN BEST INTERESTS OF STOCKHOLDERS OF AVIRAGEN \n* CAS GROUP - “BELIEVE VAXART‘S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER” \n* CAS GROUP SAYS “‍BELIEVE VAXART‘S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER AND THAT VAXART IS NOT READY TO BE A PUBLIC COMPANY”​ \n* CAS GROUP - DIGIRAD CORP, EAST HILL MANAGEMENT, THOMAS CLAY (COLLECTIVELY CAS GROUP) OWN ABOUT 8.3 PERCENT OF OUTSTANDING AVIRAGEN SHARES \n* CAS GROUP - HAS NOMINATED A SLATE OF DIRECTORS FOR AVIRAGEN‘S BOARD Source text for Eikon: Further company coverage:",
    "published": "2018-01-24T16:17:00.000+02:00",
    "crawled": "2018-01-24T16:33:54.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "group",
        "delivers",
        "letter",
        "stockholder",
        "aviragen",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "aviragen",
        "therapeutic",
        "inc",
        "ca",
        "group",
        "delivers",
        "letter",
        "stockholder",
        "aviragen",
        "ca",
        "group",
        "say",
        "proposed",
        "merger",
        "aviragen",
        "vaxart",
        "best",
        "interest",
        "stockholder",
        "aviragen",
        "ca",
        "group",
        "believe",
        "vaxart",
        "true",
        "value",
        "lower",
        "indicated",
        "proposed",
        "merger",
        "ca",
        "group",
        "say",
        "vaxart",
        "true",
        "value",
        "lower",
        "indicated",
        "proposed",
        "merger",
        "vaxart",
        "ready",
        "public",
        "company",
        "ca",
        "group",
        "digirad",
        "corp",
        "east",
        "hill",
        "management",
        "thomas",
        "clay",
        "collectively",
        "ca",
        "group",
        "percent",
        "outstanding",
        "aviragen",
        "share",
        "ca",
        "group",
        "nominated",
        "slate",
        "director",
        "aviragen",
        "board",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}